scispace - formally typeset
E

Eugene R. Hickey

Researcher at Boehringer Ingelheim

Publications -  56
Citations -  3867

Eugene R. Hickey is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Cathepsin & Cannabinoid receptor type 2. The author has an hindex of 23, co-authored 56 publications receiving 3668 citations.

Papers
More filters
Journal ArticleDOI

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.

TL;DR: A new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase is reported, requiring a large conformational change not observed previously for any of the protein Ser/Thr kinases.
Journal ArticleDOI

Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase.

TL;DR: In this article, the authors identify a biologically active HMTase inhibitor that allows for the transient modulation of H3K9me2 marks in mammalian chromatin and demonstrate that transient incubation of several cell lines with BIX-01294 lowers bulk H3 K 9me2 levels that are restored upon removal of the inhibitor.
Journal ArticleDOI

Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate.

TL;DR: A key binding domain that is distinct from the adenosine 5'-triphoshate (ATP) binding site is exposed when the conserved activation loop adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.
Journal ArticleDOI

Structural Basis of Constitutive Activity and a Unique Nucleotide Binding Mode of Human Pim-1 Kinase

TL;DR: Analysis of the reported Pim-1 kinase-domain structures leads to a hypothesis as to how Pim kinase activity might be regulated in vivo.
Patent

Aromatic heterocyclic compounds as anti-inflammatory agents

TL;DR: In this article, novel aromatic heterocyclic compounds of formula (I) wherein Ar1,Ar2,L,Q and X are described are described. And processes of making such compounds are also disclosed.